Healthcare and Life Sciences Antitrust
February 24, 2022
Intelligence That Works
BRG is home to renowned thought leaders and experts considered authorities in their fields of work. Our timely research and perspectives provide analysis and insights on the most important issues facing the industries and organizations we serve.
The Year in Review and a Look Ahead to What You Need to Know for 2022
BRG’s Ruth Tabak and Sheppard Mullin experts Bevin Newman, John Carroll, and David Garcia recapped dramatic developments in antitrust and healthcare policy under the Biden administration and looked ahead to what you need to know for 2022. Topics included:
- Ongoing overhaul of the federal agencies’ approach to M&A and merger remedies
- Increased scrutiny of provider transactions
- Developments around private equity in healthcare and life sciences
- Evolving rules on vertical transactions and arrangements
- New policies on drug pricing and competition
- Pending legislation targeting antitrust in healthcare
Related Professionals
Prepare for what's next.
ThinkSet magazine, a BRG publication, provides nuanced, multifaceted thinking and expert guidance that help today’s business leaders adopt a more strategic, long-term mindset to prepare for what’s next.